AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Etophar 600mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Baxton Pharmacia

Salt Composition

Etodolac (600mg)

Overview Etophar 600mg Tablet ER

Arthalin ER 600mg tablets offer effective pain and inflammation relief. This medication is indicated for conditions such as rheumatoid and osteoarthritis, as well as acute pain episodes. Dosage and treatment duration should strictly follow your physician's instructions. To minimize gastrointestinal discomfort, consume Arthalin ER with food or milk. Prior heart conditions or stroke history must be disclosed to your doctor. Commonly reported side effects include nausea, vomiting, indigestion, and abdominal pain. Dizziness, drowsiness, or blurred vision may also occur. For extended therapy, regular monitoring of kidney and liver function, along with blood work, is typically recommended by your doctor. Prolonged use carries potential risks including gastrointestinal bleeding and renal complications.

Uses of Etophar 600mg Tablet ER

Analgesia

Major Benefits of Etophar 600mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 600mg Etophar Extended-Release tablet whole; do not break, crush, or chew it. Administer this medicine with a meal.

Common Side effects of Etophar 600mg Tablet ER:

  • Vomiting
  • Stomach pain/epigastric pain
  • Nausea
  • Indigestion
  • Dizziness
  • Drowsiness

How to use Etophar 600mg Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Etophar 600mg Extended-Release Tablet should be taken with a meal.

How Etophar 600mg Tablet ER works:

Etophar 600mg Extended-Release tablets are a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and associated swelling.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Etophar 600mg Extended-Release Tablets with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Etophar 600mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Etophar 600mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Taking Etophar 600mg Extended-Release tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Etophar 600mg tablets appear to pose minimal risk for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary; however, medical supervision is recommended. Routine monitoring of renal function is advised during treatment.

LiverLiverCONSULT YOUR DOCTOR

Data on Etophar 600mg extended-release tablets in patients with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Etophar 600mg Tablet ER :

Should you forget a dose of Etophar 600mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Etophar 600mg Tablet ER

LabelValue
Pharmaceutical Category Compounds derived from indolylcarboxylic acids
Potential for Dependence None.
Type of Treatment Pain relievers

FAQs on Etophar 600mg Tablet ER

Etophar 600mg Extended-Release Tablets are not classified as narcotics; they are non-steroidal anti-inflammatory drugs (NSAIDs).
Etophar 600mg Extended-Release tablets are not intoxicating and do not present a risk of misuse or addiction. They do not cause physical or psychological dependency. Nevertheless, seek medical advice if you experience any adverse effects.
Patients with known allergies to Etophar 600mg Extended-Release tablets or their ingredients should not take this medication. First-time users or those unsure of potential allergic reactions should seek medical advice before initiating treatment.
Prolonged administration and substantial dosages of Etophar 600mg Extended-Release Tablets can induce renal complications, including proteinuria, hematuria, and dysuria. Individuals with a history of, or existing, congestive heart failure, nephropathy, or hypertension are predisposed to these renal adverse effects. This risk is amplified in patients concurrently using diuretics or other nephrotoxic medications. Furthermore, renal impairment is more likely in patients over 65 years of age or those experiencing dehydration. Consequently, regular assessment of renal function is advised for these patient populations.
Extended-release Etophar 600mg tablets may induce somnolence, vertigo, lassitude, and blurred vision. These side effects are infrequent and not universally experienced. Refrain from driving or operating complex equipment if these symptoms occur.
The extended-release Etophar 600mg tablet is efficacious when administered as prescribed by your physician. Continue taking the medication for the full duration of treatment, even if symptoms improve. Premature discontinuation of Etophar 600mg Tablet ER may lead to symptom recurrence or exacerbation.
Etophar 600mg Tablet ER
158
MRP 193
18% off